| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.21 | 3e-09 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-07 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-07 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.18 | 2e-07 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.17 | 6e-07 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-06 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.19 | 5e-06 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.16 | 5e-06 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.17 | 5e-06 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.15 | 8e-06 |